RE: Question for all the so claled experts on here22 Jul 2020 17:16
themuir01,
I get your frustration, especially when we see companies like SNG climb over 360% and GDR doing well.
However, AS and avct were about oncology more than anything else in my view, although the diagnostics arm including tests, definitely gained a bigger slice of the funds. With covid19 an opportunity appeared and they seized it, and they carpe diem for sure! Now we have the funds for the oncology trials. Super.
I know we all know that as it has been discussed here before. They want to bring avacta to the forefront of testing kits, not some cheap China made unreliable kit.
They are here to do science like a proper Brit company should and will stick their label on it, not to quell the needs of a bunch of small shareholders, no offence as I am included in it.
So, that's why I will wait for a good test to come out. This virus is going nowhere and tests are a must...billions of them.
ST